Maha A. Alamin

886 total citations
30 papers, 709 citations indexed

About

Maha A. Alamin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Maha A. Alamin has authored 30 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Maha A. Alamin's work include Diabetes Treatment and Management (6 papers), Cardiac Fibrosis and Remodeling (5 papers) and Cardiovascular Function and Risk Factors (4 papers). Maha A. Alamin is often cited by papers focused on Diabetes Treatment and Management (6 papers), Cardiac Fibrosis and Remodeling (5 papers) and Cardiovascular Function and Risk Factors (4 papers). Maha A. Alamin collaborates with scholars based in Saudi Arabia, Egypt and Germany. Maha A. Alamin's co-authors include Nouf M. Al‐Rasheed, Nawal M. Al‐Rasheed, Hanaa N. Al‐Ajmi, Iman H. Hasan, Raeesa A. Mohamad, Ayman M. Mahmoud, Hala Attia, Ahmed Yagi, Sakina Yagi and Amira M. Badr and has published in prestigious journals such as International Journal of Molecular Sciences, Atherosclerosis and Journal of Cellular Biochemistry.

In The Last Decade

Maha A. Alamin

29 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maha A. Alamin Saudi Arabia 16 218 160 124 81 76 30 709
Mahmoud A. Alkhateeb Saudi Arabia 18 230 1.1× 164 1.0× 111 0.9× 133 1.6× 65 0.9× 50 890
Rehab Ahmed Rifaai Egypt 17 268 1.2× 144 0.9× 81 0.7× 103 1.3× 98 1.3× 48 909
Junping Wei China 13 269 1.2× 173 1.1× 63 0.5× 97 1.2× 89 1.2× 29 689
Yu Cao China 18 345 1.6× 94 0.6× 83 0.7× 121 1.5× 97 1.3× 70 865
Eulises Díaz‐Díaz Mexico 17 214 1.0× 154 1.0× 66 0.5× 198 2.4× 60 0.8× 41 734
Maryam Mahmoudabady Iran 17 188 0.9× 212 1.3× 139 1.1× 84 1.0× 102 1.3× 55 823
Mohammad Dallak Saudi Arabia 15 131 0.6× 97 0.6× 64 0.5× 78 1.0× 75 1.0× 43 591
Fahaid Al‐Hashem Saudi Arabia 16 202 0.9× 71 0.4× 76 0.6× 125 1.5× 77 1.0× 70 819
Alicia Sánchez-Mendoza Mexico 17 252 1.2× 193 1.2× 221 1.8× 165 2.0× 43 0.6× 47 777
Alireza Shirpoor Iran 18 199 0.9× 110 0.7× 59 0.5× 108 1.3× 168 2.2× 58 876

Countries citing papers authored by Maha A. Alamin

Since Specialization
Citations

This map shows the geographic impact of Maha A. Alamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha A. Alamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha A. Alamin more than expected).

Fields of papers citing papers by Maha A. Alamin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha A. Alamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha A. Alamin. The network helps show where Maha A. Alamin may publish in the future.

Co-authorship network of co-authors of Maha A. Alamin

This figure shows the co-authorship network connecting the top 25 collaborators of Maha A. Alamin. A scholar is included among the top collaborators of Maha A. Alamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha A. Alamin. Maha A. Alamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Rasheed, Nawal M., et al.. (2025). Metformin Mitigates Diabetes-Driven Renal Senescence via Immunomodulation and the FABP4/FOXO1 Axis. Pharmaceuticals. 18(12). 1834–1834.
2.
Alamin, Maha A., Tahani K. Alshammari, Wedad S. Sarawi, et al.. (2025). Macrophage Depletion Alleviates Immunosenescence in Diabetic Kidney by Modulating GDF-15 and Klotho. International Journal of Molecular Sciences. 26(9). 3990–3990. 1 indexed citations
4.
Alshammari, Tahani K., et al.. (2024). Interplay between Senescence and Macrophages in Diabetic Cardiomyopathy: A Review of the Potential Role of GDF-15 and Klotho. Biomedicines. 12(4). 759–759. 5 indexed citations
5.
Alshammari, Tahani K., et al.. (2023). Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway. International Journal of Molecular Sciences. 24(7). 6532–6532. 14 indexed citations
6.
Khan, Mohammad Rizwan, et al.. (2023). Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression. International Journal of Molecular Sciences. 24(24). 17270–17270. 6 indexed citations
7.
Alamin, Maha A., et al.. (2023). Inflammation and Treatment-Resistant Depression from Clinical to Animal Study: A Possible Link?. Neurology International. 15(1). 100–120. 17 indexed citations
8.
Al‐Rasheed, Nawal M., et al.. (2023). Role of the integrin-linked kinase/TGF-β/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy. Journal of Pharmacy and Pharmacology. 76(1). 64–73. 7 indexed citations
9.
Al‐Rasheed, Nawal M., et al.. (2023). α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways. BMC Cardiovascular Disorders. 23(1). 153–153. 6 indexed citations
10.
Badr, Amira M., et al.. (2021). Thymol ameliorates 5‐fluorouracil‐induced intestinal mucositis: Evidence of down‐regulatory effect on TGF‐β/MAPK pathways through NF‐κB. Journal of Biochemical and Molecular Toxicology. 36(1). e22932–e22932. 22 indexed citations
11.
Attia, Hala, Nawal M. Al‐Rasheed, Nouf M. Al‐Rasheed, et al.. (2018). Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy. Biomedicine & Pharmacotherapy. 107. 347–358. 40 indexed citations
12.
Al‐Rasheed, Nawal M., Nouf M. Al‐Rasheed, Iman H. Hasan, et al.. (2018). Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes. Biomedicine & Pharmacotherapy. 105. 290–298. 61 indexed citations
13.
Al‐Rasheed, Nawal M., Nouf M. Al‐Rasheed, Iman H. Hasan, et al.. (2017). Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats. Oxidative Medicine and Cellular Longevity. 2017(1). 1092015–1092015. 116 indexed citations
14.
Mahmoud, Ayman M., Nawal M. Al‐Rasheed, Iman H. Hasan, et al.. (2016). Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats. Drug Design Development and Therapy. Volume 10. 2095–2107. 88 indexed citations
15.
Attia, Hala, Nouf M. Al‐Rasheed, Raeesa A. Mohamad, Nawal M. Al‐Rasheed, & Maha A. Alamin. (2016). The antifibrotic and fibrolytic properties of date fruit extract via modulation of genotoxicity, tissue-inhibitor of metalloproteinases and nuclear factor- kappa B pathway in a rat model of hepatotoxicity. BMC Complementary and Alternative Medicine. 16(1). 18 indexed citations
16.
Al‐Rasheed, Nawal M., Nouf M. Al‐Rasheed, Iman H. Hasan, et al.. (2015). Vitamin D attenuates pro-inflammatory TNF-α cytokine expression by inhibiting NF-кB/p65 signaling in hypertrophied rat hearts. Journal of Physiology and Biochemistry. 71(2). 289–299. 43 indexed citations
17.
Al‐Rasheed, Nawal M., Nouf M. Al‐Rasheed, Hala Attia, et al.. (2015). Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy. Pharmacology. 95(5-6). 229–239. 21 indexed citations
18.
Virk, Promy, et al.. (2013). Ameliorative effects of Embilica officinalis and Rosmarinus officinalis on cadmium-induced oxidative stress in Wistar rats. Journal of Medicinal Plants Research. 7(14). 805–818. 13 indexed citations
19.
Al‐Rasheed, Nouf M., Nawal M. Al‐Rasheed, Hala Attia, et al.. (2013). Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms?. Journal of Physiology and Biochemistry. 69(4). 761–778. 20 indexed citations
20.
Al‐Rasheed, Nouf M., et al.. (2013). Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride. Saudi Journal of Biological Sciences. 21(3). 265–274. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026